Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031

Drugs

FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
May 4, 2026, 02:41 | Drugs
FDA Approves Jakafi XR (Ruxolitinib Extended-Releas) for Myelofibrosis, Polycythemia Vera and GVHD
Jakafi XR (ruxolitinib extended-release tablets) received U.S. Food and Drug Administration approval for the treatment…
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
May 2, 2026, 14:04 | Drugs
Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo…
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Apr 27, 2026, 14:33 | Drugs
Anusha Narla: Understanding Drug-Food Interaction - Levithyroxine
Anusha Narla, Academic Team Lead at Medclinigen, shared a post on LinkedIn: "Understanding drug-food interaction:…
Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
Apr 24, 2026, 08:20 | Drugs
Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
Jack Shuang Hou, Scientific Director at Jtests and CorDx, shared on LinkedIn: ''CorTec Wins FDA…
Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
Apr 6, 2026, 16:39 | Drugs
Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
Dhinesh Selvaraju, Clinical Research Assistant at Yuva Intern by Henry Harvin, shared on LinkedIn: ''Hematopoietic…
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Apr 2, 2026, 13:51 | Drugs
Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
Clare Woodford, Head of Policy and Influencing at The Stroke Association, shared on LinkedIn: ''NICE's…
Jan Hartmann: FDA Has Approved An Expanded Indication for Haemonetics VASCADE MVP XL
Apr 1, 2026, 10:15 | Drugs
Jan Hartmann: FDA Has Approved An Expanded Indication for Haemonetics VASCADE MVP XL
Jan Hartmann, Chief Medical Officer at Haemonetics, shared on LinkedIn: ''Happy to share an important…
Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis
Mar 6, 2026, 15:09 | Drugs
Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis
Chris Simon, President and Chief Executive Officer at Haemonetics, Member of Board of Directors at…
Khaled Musallam: UAE Approves Pyrukynd for Both Alpha and Beta Thalassemia
Mar 2, 2026, 15:56 | Drugs
Khaled Musallam: UAE Approves Pyrukynd for Both Alpha and Beta Thalassemia
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared on LinkedIn: ''Some welcome and…
Jan Hartmann: NexSys Plasma Collection System Receives FDA Clearance
Feb 25, 2026, 12:53 | Drugs
Jan Hartmann: NexSys Plasma Collection System Receives FDA Clearance
Jan Hartmann, Chief Medical Officer at Haemonetics, reposted from Haemonetics on LinkedIn: ''Exciting Next Step…
All: 90 Posts: 1 - 10
NewsFeed